Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC.
about
DNA gyrase, topoisomerase IV, and the 4-quinolonesCloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IVCloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolatesAlterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitrogyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococciAlterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.Levofloxacin-resistant haemophilus influenzae, Taiwan, 2004-2010.Increase in quinolone resistance in a Haemophilus influenzae strain isolated from a patient with recurrent respiratory infections treated with ofloxacinActivities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalisIn vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections.Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea.Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.Improved antimicrobial activity of DU-6859a, a new fluoroquinolone, against quinolone-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates with alterations in GyrA and ParC proteinsGlobal fluoroquinolone resistance epidemiology and implictions for clinical use.Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children.Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.Effect of Fluoroquinolones and Macrolides on Eradication and Resistance of Haemophilus influenzae in Chronic Obstructive Pulmonary DiseaseThe use of platensimycin and platencin to fight antibiotic resistance.Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolDynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains.Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV.Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.Molecular characterization of the gene encoding the DNA gyrase A subunit of Streptococcus pneumoniaeQuinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacinRapid screening of point mutations of the Neisseria gonorrhoeae parC gene associated with resistance to quinolonesIn vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities.Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.Use of the riboflavin synthase gene (ribC) as a model for development of an essential gene disruption and complementation system for Haemophilus influenzae.Melting curve analysis for rapid detection of topoisomerase gene mutations in Haemophilus influenzae.Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability.Quinolone resistance-determining regions of gyrA and parC in Pasteurella multocida strains with different levels of nalidixic acid resistance.Novel combination of mutations in the DNA gyrase and topoisomerase IV genes in laboratory-grown fluoroquinolone-resistant Shigella flexneri mutants.
P2860
Q24643546-E4B1EF06-3FD3-4DA7-A201-B49D49315DC6Q28492734-5550F090-A8D7-47BA-9754-3518F3A874D8Q33690745-47EA8739-E042-42AD-8C87-D3D300E62D7BQ33696730-6B0D23B2-C437-4DA6-89A4-8B151A27F32DQ33699643-F55D6ADD-D984-4B3A-9B95-B1C4ECA7DC07Q33700561-5DADF9E9-CB69-4D88-BCA7-A40A7120E755Q33805682-CF8B6265-6B46-47B4-B2AC-F3569F475B66Q33951148-900EB018-91EB-49AD-B4AC-E12465DA83C4Q33975927-F078CA27-0BA9-48B8-80C3-22276BF7D141Q33978946-7103A25F-4809-4CF8-8139-3F887E92544AQ33981178-4711C8B7-D90F-42CE-9868-813AC7EDBED6Q34297656-B560F271-3154-4F02-8614-AD4E668F03D1Q34572722-5B3E502E-B39E-425B-89D9-508F16CED309Q34922753-01DEC5D1-862D-48C2-8F9A-9ACEF96790E2Q35139054-2A9BF67A-B399-4EED-B398-5081B1ADD761Q36337074-21C2037C-948E-42D0-80C0-57831E87AA0CQ36423756-F9930E85-536E-4596-9E24-2990B506624CQ36546371-D0A15198-75B1-4216-A34D-0D09576D88ABQ37023332-93ECEF2E-1E76-4994-9C10-8B4CEE94ABA7Q37203095-9B7ACBA7-CC00-483B-8B5F-9E108DD0B44EQ37392760-2015E98D-535E-482F-AC93-F87D24D95A65Q37421041-45156D9B-453D-43FF-B430-E05235640165Q37488787-83B729BB-B56E-4E9F-8198-181506BA1001Q39559460-E8F0A09E-5445-4217-AF98-750D49105907Q39566212-588EFCE2-8AB5-441B-A3AE-C9C7CAD2C6F3Q39698735-49FB0003-E7E5-417B-8CED-BEA4640C29BAQ40013419-82A035E4-A84F-4C40-A4ED-4FD1AC746F26Q40130597-F195F810-C7AC-49C6-AE4F-808883DE1E32Q40638334-CF5A126B-5DF7-4536-8619-C18BAAECC059Q41031281-E2AA7F8F-33FE-4794-8BEC-7957A44910A2Q41873346-F5EC4CB1-32B1-4854-B6D8-24E6B3BAC6D1Q41991607-A48A38FD-54C0-4E23-AC68-C8DB974FCEB1Q42730336-04FD90F0-A652-4F87-9D0E-8F5968B291DAQ42743898-5F0C6E4C-EB3C-4885-A52A-EAA94E0E57AF
P2860
Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Ciprofloxacin-resistant Haemop ...... us positions of GyrA and ParC.
@ast
Ciprofloxacin-resistant Haemop ...... us positions of GyrA and ParC.
@en
type
label
Ciprofloxacin-resistant Haemop ...... us positions of GyrA and ParC.
@ast
Ciprofloxacin-resistant Haemop ...... us positions of GyrA and ParC.
@en
prefLabel
Ciprofloxacin-resistant Haemop ...... us positions of GyrA and ParC.
@ast
Ciprofloxacin-resistant Haemop ...... us positions of GyrA and ParC.
@en
P2093
P2860
P356
P1476
Ciprofloxacin-resistant Haemop ...... ous positions of GyrA and ParC
@en
P2093
P2860
P304
P356
10.1128/AAC.40.7.1741
P407
P577
1996-07-01T00:00:00Z